We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

27 hedge funds and large institutions have $21.5M invested in Ocera Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

4% less capital invested

Capital invested by funds: $22.4M → $21.5M (-$870K)

16% less funds holding

Funds holding: 32 → 27 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
27
Holders Change
-5
Holders Change %
-15.63%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$1.92M
2
TI
Turner Investments
Pennsylvania
+$1.62M
3
QF
QVT Financial
New York
+$625K
4
SM
Sabby Management
Florida
+$181K
5
Millennium Management
Millennium Management
New York
+$125K

Top Sellers

Rank Fund Capital Flow
1
OPPM
Opus Point Partners Management
New York
-$709K
2
JP Morgan Chase
JP Morgan Chase
New York
-$275K
3
ECM
Endurant Capital Management
California
-$208K
4
Citadel Advisors
Citadel Advisors
Florida
-$38K
5
Morgan Stanley
Morgan Stanley
New York
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPP
1
Great Point Partners
Connecticut
$6.21M – – –
QF
2
QVT Financial
New York
$2.32M +$625K +162,451 +28%
VM
3
VHCP Management
New York
$2.22M – – –
Millennium Management
4
Millennium Management
New York
$1.74M +$125K +32,470 +6%
TI
5
Turner Investments
Pennsylvania
$1.65M +$1.62M +421,199 +421%
SFM
6
Sphera Funds Management
Israel
$1.58M +$1.92M +500,000 New
SM
7
Sabby Management
Florida
$1.35M +$181K +46,970 +12%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.16M +$42.6K +11,069 +3%
WMSA
9
Weiss Multi-Strategy Advisers
New York
$624K +$9.35K +2,429 +1%
ECM
10
Endurant Capital Management
California
$560K -$208K -54,020 -23%
PVI
11
Pura Vida Investments
New York
$414K +$52.3K +13,581 +12%
GTC
12
Ghost Tree Capital
New York
$395K – – –
BCM
13
Bridgeway Capital Management
Texas
$262K +$77K +20,000 +32%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$191K -$9.33K -2,424 -4%
Renaissance Technologies
15
Renaissance Technologies
New York
$184K +$88.5K +23,000 +65%
Stifel Financial
16
Stifel Financial
Missouri
$111K +$2.95K +767 +2%
BFA
17
BlackRock Fund Advisors
California
$109K -$3.51K -912 -3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$108K – – –
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$97K – – –
NI
20
Numeric Investors
Massachusetts
$59K +$71.6K +18,600 New
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$40K +$1.7K +441 +4%
Northern Trust
22
Northern Trust
Illinois
$40K +$49.2K +12,786 New
GT
23
Glenmede Trust
Pennsylvania
$35K – – –
Deutsche Bank
24
Deutsche Bank
Germany
$33K +$39.8K +10,343 +2,818%
BIM
25
BlackRock Investment Management
Delaware
$7K – – –
1
2

OCRX Hedge Fund Activity: Q3 2015 in Review

27 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q3 2015, worth a combined $21.5M — down 3.9% from $22.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of OCRX and 3 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 12 added.

The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.92M. The largest seller was Opus Point Partners Management, exiting entirely with an estimated $709K sold.

  • 27 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q3 2015, down from 32 in Q2 2015.
  • Funds reported $21.5M of Ocera Therapeutics, Inc. stock for Q3 2015, down 3.9% quarter-over-quarter.
  • 3 funds opened new Ocera Therapeutics, Inc. positions in Q3 2015 and 8 closed out, a net change of -5 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q3 2015 was Sphera Funds Management, an estimated $1.92M added.
  • The largest Ocera Therapeutics, Inc. seller in Q3 2015 was Opus Point Partners Management, an estimated $709K sold.

Based on aggregated 13F filings for Q3 2015.